Ju‐Ming Wang
Impact in
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer Cells and Metastasis
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- Genomics and Chromatin Dynamics 6
- Epigenetics and DNA Methylation 4
- Peroxisome Proliferator-Activated Receptors 4
- Co-authors
- Hsin‐Fang Yang‐Yen (4 shared papers)Wen‐Chang Chang (18 shared papers)Chiung‐Yuan Ko (16 shared papers)Jyh-Rong Chao (2 shared papers)Min‐Liang Kuo (2 shared papers)Chien-Feng L Li (17 shared papers)Wannhsin Chen (1 shared paper)Min-Hsiung Pan (5 shared papers)
- Journals
- Journal of Biomedical Science (5 papers)Clinical Cancer Research (4 papers)Oncotarget (4 papers)Molecular and Cellular Biology (4 papers)Cell Death Discovery (3 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ju‐Ming Wang
72 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 96
- Oncology 677
- Cancer Research 318
- Molecular Biology 1.4k
- Immunology 380
- Genetics 125
Countries citing papers authored by Ju‐Ming Wang
This map shows the geographic impact of Ju‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Ming Wang more than expected).
Fields of papers citing papers by Ju‐Ming Wang
This network shows the impact of papers produced by Ju‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Ming Wang. The network helps show where Ju‐Ming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju‐Ming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 532 | |
| 2 | 1999 | 324 | |
| 3 | 1998 | 170 | |
| 4 | 2009 | 133 | |
| 5 | 2012 | 130 | |
| 6 | 2015 | 122 | |
| 7 | 2010 | 102 | |
| 8 | 2009 | 93 | |
| 9 | 2006 | 92 | |
| 10 | 2008 | 80 | |
| 11 | 2003 | 74 | |
| 12 | 2010 | 73 | |
| 13 | 2010 | 62 | |
| 14 | 2015 | 59 | |
| 15 | 2017 | 59 | |
| 16 | 2011 | 58 | |
| 17 | 2016 | 54 | |
| 18 | 2012 | 53 | |
| 19 | 2015 | 52 | |
| 20 | 2009 | 47 |
About Ju‐Ming Wang
Ju‐Ming Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Neurology, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Genomics and Chromatin Dynamics (6 papers), Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Biomarkers in Disease Mechanisms (4 papers), Epigenetics and DNA Methylation (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Oncology (677 citations), Cancer Research (318 citations), Molecular Biology (1.4k citations), Immunology (380 citations) and Genetics (125 citations). Ju‐Ming Wang has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Hsin‐Fang Yang‐Yen, Wen‐Chang Chang, Chiung‐Yuan Ko, Jyh-Rong Chao, Min‐Liang Kuo, Chien-Feng L Li, Wannhsin Chen, Min-Hsiung Pan, Thomas P. Loughran and Yongxiang Li. Their work appears in journals such as Journal of Biomedical Science, Clinical Cancer Research, Oncotarget, Molecular and Cellular Biology and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.